Delivery Order SPE2DR25D3301-SPE2DR26F20RA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Methylphenidate 5 mg chewable tablets (100 count) with a ceiling value of $3,579.31. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for completion by January 15, 2026, and will be performed at the awardee's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 2.5 mg chewable tablets (100-count units) with a contract value of $1,620.98. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, under a firm fixed-price delivery order structure. The contract was competitively awarded with no set-aside designation, and performance is based at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,232.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) on January 13, 2026, with a completion date of January 14, 2026. This non-set-aside, competitively awarded contract features firm fixed-price pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.50 to AmerisourceBergen Drug Corp for the supply of methylphenidate 2.5 mg chewable tablets (100-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 9, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of methylphenidate 5 mg chewable tablets (100-count bottles) with a contract ceiling value of $1,734.28. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a ceiling value of $6,686.71 under firm fixed pricing. This is a non-set-aside contract, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.56 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed-price contract. The delivery order was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and is classified as a non-set-aside competitive award. Performance will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,573.89 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units) under a firm fixed-price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, with no set-aside designation applied. Performance will be completed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20RADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Methylphenidate 2.5 mg chewable tablets (100 count) with a ceiling value of $1,053.00. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of January 14, 2026. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including deliveries to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Methylphenidate, a central nervous system stimulant, is commonly used in military and veteran healthcare settings for attention deficit hyperactivity disorder treatment, reflecting the typical therapeutic product portfolio maintained under the DLA medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/12/26 |